Does moxifloxacin cause abnormal liver function tests?

Does Moxifloxacin Cause Deranged LFTs?

Yes, moxifloxacin can cause deranged liver function tests, ranging from common transient elevations to rare but potentially fatal acute hepatitis.

Hepatic Adverse Effects Profile

Moxifloxacin has a well-documented spectrum of hepatotoxicity 1:

Common Effects

• Transient increases in LFTs are listed as a common adverse effect 1
• These mild elevations typically resolve without intervention

Serious Effects (Rare)

• Acute hepatitis (rare) 1
• Fulminant hepatitis potentially leading to liver failure, including fatal cases 1
• Fatal hepatotoxicity has been documented in case reports, including a 72-year-old man who developed jaundice one week after treatment and subsequently died from acute hepatic failure 2

Clinical Monitoring Requirements

Routine toxicity monitoring tests including LFTs should be performed intermittently throughout antibiotic treatment when moxifloxacin is used for conditions like non-tuberculous mycobacterial pulmonary disease 1.

Key Monitoring Points:

• Baseline LFTs before initiating therapy
• Intermittent monitoring during treatment
• Immediate assessment if symptoms develop (nausea, vomiting, jaundice, right upper quadrant pain, dark urine)

Contraindications and Cautions

Moxifloxacin is contraindicated in patients with:

• Chronic liver disease, particularly Child-Pugh severity score C
• Transaminase levels ≥5 times the upper limit of normal 1

In these patients, consider using levofloxacin as an alternative 1.

Warning Signs Requiring Immediate Action:

• Loss of appetite, nausea, vomiting
• Fever, weakness, tiredness
• Right upper quadrant tenderness
• Itching, yellowing of skin/eyes
• Light-colored stools or dark urine 3

Management Algorithm

1. Before starting moxifloxacin:

   • Check baseline LFTs
   • Assess for pre-existing liver disease
   • Document Child-Pugh score if cirrhosis present

2. During treatment:

   • Monitor for symptoms of hepatotoxicity
   • Perform intermittent LFTs (frequency based on risk factors)
   • If AST/ALT >3× ULN with symptoms OR >5× ULN without symptoms: discontinue immediately 4

3. If hepatotoxicity develops:

   • Stop moxifloxacin immediately
   • Rule out other causes (viral hepatitis, other hepatotoxins, alcohol)
   • Consider alternative antibiotics without hepatotoxicity (e.g., aminoglycosides, other fluoroquinolones like levofloxacin)

Important Clinical Context

The FDA drug label explicitly warns that severe hepatotoxicity including acute hepatitis and fatal events have been reported 3. While the overall incidence is low, the potential for severe outcomes means vigilance is essential. Research has shown that drug-induced liver injury from antibiotics, including fluoroquinolones, can occasionally lead to acute liver failure requiring transplantation or resulting in death 5.

The key pitfall is failing to recognize early symptoms of hepatotoxicity. Patients must be counseled to report any signs of liver injury immediately, and clinicians should have a low threshold for checking LFTs if symptoms develop.